$7.93
13.61% today
Nasdaq, Aug 22, 10:20 pm CET
ISIN
US39959A2050
Symbol
UPXI

Upexi Stock price

$7.93
+0.23 2.99% 1M
+4.19 112.03% 6M
+4.42 125.92% YTD
+4.11 107.48% 1Y
-92.87 92.13% 3Y
-104.07 92.92% 5Y
-104.07 92.92% 10Y
-104.07 92.92% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.95 13.61%
ISIN
US39959A2050
Symbol
UPXI

Key metrics

Basic
Market capitalization
$411.0m
Enterprise Value
$418.1m
Net debt
$7.1m
Cash
$230.0k
Shares outstanding
1.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | 4.0
EV/Sales
negative | 4.0
EV/FCF
negative
P/B
222.2
Financial Health
Equity Ratio
27.7%
Return on Equity
-363.1%
ROCE
-274.0%
ROIC
-99.3%
Debt/Equity
3.9
Financials (TTM | estimate)
Revenue
$-22.1m | $103.8m
EBITDA
$-10.6m | $7.4m
EBIT
$-11.7m | $-898.6k
Net Income
$-22.5m | $-9.9m
Free Cash Flow
$-1.5m
Growth (TTM | estimate)
Revenue
-121.1% | 299.0%
EBITDA
-303.8% | 176.4%
EBIT
-27.9% | 93.3%
Net Income
8.6% | 58.1%
Free Cash Flow
80.4%
Margin (TTM | estimate)
Gross
-16.2%
EBITDA
48.1% | 7.2%
EBIT
-
Net
102.0% | -9.6%
Free Cash Flow
-
More
EPS
$-16.8
FCF per Share
$-1.1
Short interest
12.4%
Employees
64
Rev per Employee
$410.0k
Show more

Is Upexi a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Upexi Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Upexi forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Upexi forecast:

Buy
86%
Hold
14%

Financial data from Upexi

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
-22 -22
121% 121%
100%
- Direct Costs -26 -26
136% 136%
-
3.57 3.57
89% 89%
-
- Selling and Administrative Expenses 15 15
58% 58%
-
- Research and Development Expense - -
-
-
-11 -11
304% 304%
-
- Depreciation and Amortization 1.08 1.08
83% 83%
-
EBIT (Operating Income) EBIT -12 -12
28% 28%
-
Net Profit -23 -23
9% 9%
-

In millions USD.

Don't miss a Thing! We will send you all news about Upexi directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Upexi Stock News

Neutral
PRNewsWire
11 days ago
NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Upexi, Inc. (NASDAQ: UPXI) on behalf of the company's shareholders.  The investigation seeks to determine whether Upexi's directors breached their fiduciary duties in connection with recent corporate actions.
Neutral
GlobeNewsWire
about one month ago
Upexi purchased an additional 100,000 SOL, and anticipates it may generate up to approximately $26 million in annual staking revenue based on current SOL holdings Company releases adjusted metrics for enhanced transparency and analysis
Neutral
GlobeNewsWire
about one month ago
TAMPA, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space, today announced the closing of a private placement equity offering of 12,457,186 shares of common stock (the “Equity Offering”) with certain acc...
More Upexi News

Company Profile

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.

Head office United States
CEO Allan Marshall
Employees 64
Website upexi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today